Abstract 4228: Integrated drug high-throughput screening and quantitative phosphoproteomics rationalizes combination therapy for mutant KRAS pancreatic cancer
Authors: Joseph Capri, Thuc Le, Caius Radu, Timothy Donahue
Published: 2019-08-07
DOI:
10.1158/1538-7445.am2019-4228
Source:
Full article
Abstract
Abstract